<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2016.00234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>General Commentary</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Commentary: Distribution of 5-HT<sub>1F</sub> Receptors in Monkey Vestibular and Trigeminal Ganglion Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Valen&#x000E7;a</surname> <given-names>Marcelo M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/13433"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Neurosurgery and Neurology Unit, Hospital das Cl&#x000ED;nicas, Federal University of Pernambuco, Cidade Universit&#x000E1;ria</institution>, <addr-line>Recife, Pernambuco</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Milena De Felice, University of Sheffield, UK</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Greg Dussor, University of Texas at Dallas, USA</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Marcelo M. Valen&#x000E7;a, <email>mmvalenca&#x00040;yahoo.com.br</email></corresp>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Headache Medicine and Facial Pain, a section of the journal Frontiers in Neurology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>234</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Valen&#x000E7;a.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Valen&#x000E7;a</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front Neurol" journal-id-type="nlm-ta" vol="7" page="173" xlink:href="27777567" ext-link-type="pubmed">A Commentary on <article-title>Distribution of 5-HT<sub>1F</sub> Receptors in Monkey Vestibular and Trigeminal Ganglion Cells</article-title> by Usman HO, Balaban CD. Front Neurol (2016) 7:173. doi: <object-id>10.3389/fneur.2016.00173</object-id></related-article>
<kwd-group>
<kwd>serotonin</kwd>
<kwd>vestibular migraine</kwd>
<kwd>vomiting</kwd>
<kwd>receptor</kwd>
<kwd>pathophysiology</kwd>
<kwd>headache</kwd>
<kwd>5-HT</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="23"/>
<page-count count="3"/>
<word-count count="1776"/>
</counts>
</article-meta>
</front>
<body>
<p>Based on the assumption that a congruence exists between the expression of serotonin (5-hydroxytryptamine, 5-HT) receptors and vestibular pathways, Usman and Balaban (<xref ref-type="bibr" rid="B1">1</xref>) showed the distribution of 5-HT<sub>1F</sub> receptors in vestibular and trigeminal ganglia, including blood vessels, in the monkey. They also discussed the relationship between the 5-HT<sub>1F</sub> receptor and 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors, using previously data from their laboratory. They logically explain possible interactions of triptans on 5-HT<sub>1F</sub> receptors (triptans also activate 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors) and also point out that serotonin may be involved in the pathophysiology of some migrainous features (e.g., tinnitus and phonophobia) in vestibular migraine.</p>
<p>In the central nervous system (CNS), serotonin neurons are involved in functions such as appetite, sleep, mood, thermoregulation, anxiety, aggression, learning and cognition, also inducing feelings of well-being and happiness. Serotonin is also an important vasoconstrictor, which may account for the vasomotor changes observed during a migraine attack.</p>
<p>Serotonin, a monoamine neurotransmitter, is encountered in significant quantities in the CNS and gastrointestinal tract. Nausea and vomiting are pathognomonic features of a migraine attack, and serotonin agonists may be a strong vomiting and nausea trigger. Furthermore, reduction in brain synthesis of serotonin by tryptophan depletion was able to provoke more intense headache, nausea, and photophobia in migraine patients (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>In vestibular migraine, the balance disorder is often associated with nausea and vomiting, again pointing to the pivotal role of the central serotonergic system in the pathophysiology of migraine (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>The evolutionary role of serotonin in feeding, i.e., food selection and absorption, must have occurred. Particular types of food or beverage may trigger migraine attacks (<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B7">7</xref>). In contrast, attacks are also provoked by fasting (<xref ref-type="bibr" rid="B8">8</xref>). Poisonous or toxic food is eliminated by induced vomiting or diarrhea through a serotonergic mechanism. Curiously, on the phylogenetic scale, serotonin may be found in fungi and plants (<xref ref-type="bibr" rid="B9">9</xref>). Plant spines and some venoms secreted by insects may contain serotonin, which causes pain in the threatening animal to ward off the danger. This also shows its important role in self-defense and induction of pain, even in primitive forms of life.</p>
<p>Serotonin is also encountered in some seeds and fruits, helping the digestive function. Ninety percent of the serotonin of the body is located in the gastrointestinal tract (enterochromaffin cells), whose function is to regulate gastrointestinal mobility, fundamental in food absorption. There is a bidirectional communication between gut and CNS. The gut transmits information to CNS through multiple forms, including vagal and spinal neurons, and gut receives CNS outputs by autonomic neurons and neuroendocrine regulation (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>An evolutionary role of migraine in guaranteeing survival and successful reproduction was described (<xref ref-type="bibr" rid="B11">11</xref>). Migraine probably exerted a role in the organization of the world&#x02019;s first cities, transforming a previously nomadic existence into a sedentary way of life (<xref ref-type="bibr" rid="B12">12</xref>). Conditions such as incapacitating migraine attacks, pregnancy, lactation, and menses may well be states that led our species to its present-day &#x0201C;civilized&#x0201D; way of life (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Some individuals present a worsening in their migraine attacks when changes in the environment occur, e.g., emotional or physical stress. Regarding feeding, distinct smells, specific food ingestion, and food privation might all have triggered migraines in these migraine-prone individuals who, by changing their behavior, may have forced the entire group to reconsider their previous migratory way of life (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>My main comment on serotonin and its relation to vomiting is that, since the time of Hippocrates, it has been known that, in some individuals suffering a migraine attack, the crisis is completely relieved after an episode of vomiting (<xref ref-type="bibr" rid="B13">13</xref>). Some migraineurs, on realizing that an episode of vomiting can stop a migraine attack, induce vomiting in order to curtail the attack (<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>). In some series, up to 15% of the migraineurs reported using induced vomiting in an attempt to bring to an end a migraine crisis (<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>The question still to be answered is: why does this occur? Interestingly, to date, no drug has been able to provide immediate relief of the migraine pain. The good therapeutic response expected with the use of analgesic and migraine-specific drugs is a progressive decrease in the pain intensity lasting up to 2&#x02009;h in migraineurs. In this context, Chai and coworkers (<xref ref-type="bibr" rid="B10">10</xref>) recently discussed some hypotheses for how vomiting could stop migraine attacks.</p>
<p>Serotonin antagonists have largely been used as antiemetic drugs, particularly 5-HT<sub>3</sub> receptor antagonist (<xref ref-type="bibr" rid="B17">17</xref>), but their effects on the pain are weak or non-existent. There is clearly a myriad of different serotonin receptor subtypes, each of which has a particular function depending on the neuronal system where it is located and on the various inputs that may influence the neuronal response. The chemoreceptor trigger zone in the <italic>area postrema</italic>, a brain structure that acts as a vomit-inducing center in the medulla, has different subtypes of serotonin receptors and, due to the absence of the blood&#x02013;brain barrier, circulating substances in the blood or cerebrospinal fluid may either inhibit or stimulate the mechanism of vomiting.</p>
<p>Over the past few decades, a number of drugs that act on serotonin receptors or by regulating the serotonin concentration in synapses have been developed and introduced in clinical practice, both to treat acute headache attacks and to preventively control incapacitating crises in a migraineur.</p>
<p>Interestingly, serotonin-modulating drugs such as reuptake inhibitors (e.g., fluoxetine and citalopram) have no clear efficacy for migraine prevention but also do not seem to make migraine attacks any worse. The marginal beneficial effects (<xref ref-type="bibr" rid="B18">18</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>), if any, on the migrainous features claimed by some, may also be due to control of the depressive and anxiety symptoms by these antidepressants/anxiolytics drugs, depression and anxiety being comorbidities, which might influence the frequency of migraine attacks (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Even now, with all the information available on serotonin and its receptors, we are still far from elucidating the mechanism involved in a migraine attack. Thus, studies such as this (<xref ref-type="bibr" rid="B1">1</xref>) are essential for understanding the pathogenesis of migraine and planning a rational form of treatment (<xref ref-type="bibr" rid="B23">23</xref>). Understanding the mechanism through which vomiting may interrupt a migraine attack may also help in the development of new drugs with a more effective action in interrupting migraine attacks more swiftly (see Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>The role of serotonin in migraine physiopathogenesis, phylogenetic scale, human evolution, and drug development</bold>.</p></caption>
<graphic xlink:href="fneur-07-00234-g001.tif"/>
</fig>
<sec id="S1" sec-type="author-contributor">
<title>Author Contributions</title>
<p>The author confirms being the sole contributor of this work and approved it for publication.</p>
</sec>
<sec id="S2">
<title>Conflict of Interest Statement</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Usman</surname> <given-names>HO</given-names></name> <name><surname>Balaban</surname> <given-names>CD</given-names></name></person-group>. <article-title>Distribution of 5-HT1F receptors in monkey vestibular and trigeminal ganglion cells</article-title>. <source>Front Neurol</source> (<year>2016</year>) <volume>7</volume>:<fpage>173</fpage>.<pub-id pub-id-type="doi">10.3389/fneur.2016.00173</pub-id><pub-id pub-id-type="pmid">27777567</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname> <given-names>PD</given-names></name></person-group>. <article-title>Tryptophan depletion increases nauseas, headache and photophobia in migraine sufferers</article-title>. <source>Cephalalgia</source> (<year>2006</year>) <volume>26</volume>:<fpage>1225</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01212.x</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stolte</surname> <given-names>B</given-names></name> <name><surname>Holle</surname> <given-names>D</given-names></name> <name><surname>Naegel</surname> <given-names>S</given-names></name> <name><surname>Diener</surname> <given-names>HC</given-names></name> <name><surname>Obermann</surname> <given-names>M</given-names></name></person-group>. <article-title>Vestibular migraine</article-title>. <source>Cephalalgia</source> (<year>2015</year>) <volume>35</volume>(<issue>3</issue>):<fpage>262</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1177/0333102414535113</pub-id><pub-id pub-id-type="pmid">24847169</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krymchantowski</surname> <given-names>AV</given-names></name> <name><surname>da Cunha Jevoux</surname> <given-names>C</given-names></name></person-group>. <article-title>Wine and headache</article-title>. <source>Headache</source> (<year>2014</year>) <volume>54</volume>(<issue>6</issue>):<fpage>967</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1111/head.12365</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>VT</given-names></name> <name><surname>Vij</surname> <given-names>B</given-names></name></person-group>. <article-title>Diet and headache: part 1</article-title>. <source>Headache</source> (<year>2016</year>) <volume>56</volume>(<issue>9</issue>):<fpage>1543</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1111/head.12953</pub-id><pub-id pub-id-type="pmid">27699780</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>VT</given-names></name> <name><surname>Vij</surname> <given-names>B</given-names></name></person-group>. <article-title>Diet and headache: part 2</article-title>. <source>Headache</source> (<year>2016</year>) <volume>56</volume>(<issue>9</issue>):<fpage>1553</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/head.12952</pub-id><pub-id pub-id-type="pmid">27699772</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaeem</surname> <given-names>Z</given-names></name> <name><surname>Zhou</surname> <given-names>L</given-names></name> <name><surname>Dilli</surname> <given-names>E</given-names></name></person-group>. <article-title>Headaches: a review of the role of dietary factors</article-title>. <source>Curr Neurol Neurosci Rep</source> (<year>2016</year>) <volume>16</volume>(<issue>11</issue>):<fpage>101</fpage>.<pub-id pub-id-type="doi">10.1007/s11910-016-0702-1</pub-id><pub-id pub-id-type="pmid">27714637</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>DP</given-names></name> <name><surname>Smitherman</surname> <given-names>TA</given-names></name> <name><surname>Penzien</surname> <given-names>DB</given-names></name> <name><surname>Porter</surname> <given-names>JA</given-names></name> <name><surname>Martin</surname> <given-names>VT</given-names></name> <name><surname>Houle</surname> <given-names>TT</given-names></name></person-group>. <article-title>Nighttime snacking, stress, and migraine activity</article-title>. <source>J Clin Neurosci</source> (<year>2014</year>) <volume>21</volume>(<issue>4</issue>):<fpage>638</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.jocn.2013.08.013</pub-id><pub-id pub-id-type="pmid">24417796</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erland</surname> <given-names>LA</given-names></name> <name><surname>Turi</surname> <given-names>CE</given-names></name> <name><surname>Saxena</surname> <given-names>PK</given-names></name></person-group>. <article-title>Serotonin: an ancient molecule and an important regulator of plant processes</article-title>. <source>Biotechnol Adv</source> (<year>2016</year>) <volume>34</volume>(<issue>8</issue>):<fpage>1347</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.biotechadv.2016.10.002</pub-id><pub-id pub-id-type="pmid">27742596</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname> <given-names>NC</given-names></name> <name><surname>Shapiro</surname> <given-names>RE</given-names></name> <name><surname>Rapoport</surname> <given-names>AM</given-names></name></person-group>. <article-title>Why does vomiting stop a migraine attack?</article-title> <source>Curr Pain Headache Rep</source> (<year>2013</year>) <volume>17</volume>(<issue>9</issue>):<fpage>362</fpage>.<pub-id pub-id-type="doi">10.1007/s11916-013-0362-7</pub-id><pub-id pub-id-type="pmid">23913116</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loder</surname> <given-names>E</given-names></name></person-group>. <article-title>What is the evolutionary advantage of migraine?</article-title> <source>Cephalalgia</source> (<year>2002</year>) <volume>22</volume>(<issue>8</issue>):<fpage>624</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1046/j.1468-2982.2002.00437.x</pub-id><pub-id pub-id-type="pmid">12383059</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valen&#x000E7;a</surname> <given-names>MM</given-names></name> <name><surname>da Silva</surname> <given-names>AA</given-names></name> <name><surname>Bordini</surname> <given-names>CA</given-names></name></person-group>. <article-title>Headache research and medical practice in Brazil: an historical overview</article-title>. <source>Headache</source> (<year>2015</year>) <volume>55</volume>(<issue>Suppl 1</issue>):<fpage>4</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/head.12512</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname> <given-names>JM</given-names></name></person-group>. <article-title>Historical aspects of migraine</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>1986</year>) <volume>49</volume>:<fpage>1097</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.49.10.1097</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname> <given-names>IP</given-names></name> <name><surname>Parreira</surname> <given-names>E</given-names></name></person-group>. <article-title>Behavioral response to headache: a comparison between migraine and tension-type headache</article-title>. <source>Headache</source> (<year>2001</year>) <volume>41</volume>:<fpage>546</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1046/j.1526-4610.2001.041006546.x</pub-id><pub-id pub-id-type="pmid">11437889</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bag</surname> <given-names>B</given-names></name> <name><surname>Karabulut</surname> <given-names>N</given-names></name></person-group>. <article-title>Pain-relieving factors in migraine and tension type headache</article-title>. <source>Int J Clin Pract</source> (<year>2005</year>) <volume>59</volume>:<fpage>760</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1111/j.1368-5031.2005.00535.x</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>R</given-names></name> <name><surname>Bhatia</surname> <given-names>MS</given-names></name></person-group>. <article-title>A report of cranial autonomic symptoms in migraineurs</article-title>. <source>Cephalalgia</source> (<year>2007</year>) <volume>27</volume>:<fpage>22</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01237.x</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaikh</surname> <given-names>SI</given-names></name> <name><surname>Nagarekha</surname> <given-names>D</given-names></name> <name><surname>Hegade</surname> <given-names>G</given-names></name> <name><surname>Marutheesh</surname> <given-names>M</given-names></name></person-group>. <article-title>Postoperative nausea and vomiting: a simple yet complex problem</article-title>. <source>Anesth Essays Res</source> (<year>2016</year>) <volume>10</volume>(<issue>3</issue>):<fpage>388</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.4103/0259-1162.179310</pub-id><pub-id pub-id-type="pmid">27746521</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarlaci</surname> <given-names>S</given-names></name></person-group>. <article-title>Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders</article-title>. <source>Clin Neuropharmacol</source> (<year>2009</year>) <volume>32</volume>(<issue>5</issue>):<fpage>254</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/WNF.0b013e3181a8c84f</pub-id><pub-id pub-id-type="pmid">19667978</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rampello</surname> <given-names>L</given-names></name> <name><surname>Alvano</surname> <given-names>A</given-names></name> <name><surname>Chiechio</surname> <given-names>S</given-names></name> <name><surname>Malaguarnera</surname> <given-names>M</given-names></name> <name><surname>Raffaele</surname> <given-names>R</given-names></name> <name><surname>Vecchio</surname> <given-names>I</given-names></name> <etal/></person-group> <article-title>Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache</article-title>. <source>Neuropsychobiology</source> (<year>2004</year>) <volume>50</volume>(<issue>4</issue>):<fpage>322</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1159/000080960</pub-id><pub-id pub-id-type="pmid">15539864</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname> <given-names>JL</given-names></name> <name><surname>Cogbill</surname> <given-names>E</given-names></name> <name><surname>Santana-Davila</surname> <given-names>R</given-names></name> <name><surname>Eldredge</surname> <given-names>C</given-names></name> <name><surname>Collier</surname> <given-names>W</given-names></name> <name><surname>Gradall</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>(<issue>7</issue>):<fpage>e0130733</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0130733</pub-id><pub-id pub-id-type="pmid">26172390</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Finocchi</surname> <given-names>C</given-names></name> <name><surname>Villani</surname> <given-names>V</given-names></name> <name><surname>Casucci</surname> <given-names>G</given-names></name></person-group>. <article-title>Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence</article-title>. <source>Neurol Sci</source> (<year>2010</year>) <volume>31</volume>(<issue>Suppl 1</issue>):<fpage>S95</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/s10072-010-0297-2</pub-id><pub-id pub-id-type="pmid">20464594</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname> <given-names>JL</given-names></name> <name><surname>Razavi</surname> <given-names>M</given-names></name></person-group>. <article-title>Pharmacological management of mood and anxiety disorders in headache patients</article-title>. <source>Headache</source> (<year>2006</year>) <volume>46</volume>(<issue>Suppl 3</issue>):<fpage>S133</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00564.x</pub-id><pub-id pub-id-type="pmid">17034391</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuster</surname> <given-names>NM</given-names></name> <name><surname>Rapoport</surname> <given-names>AM</given-names></name></person-group>. <article-title>New strategies for the treatment and prevention of primary headache disorders</article-title>. <source>Nat Rev Neurol</source> (<year>2016</year>) <volume>12</volume>(<issue>11</issue>):<fpage>635</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/nrneurol.2016.143</pub-id><pub-id pub-id-type="pmid">27786243</pub-id></citation></ref>
</ref-list>
</back>
</article>